| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Total Income - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Total Expenses - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Gross Profit/Loss - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Net Profit/Loss - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
Check the financial reports for the company - Stil Biotechnology S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Current Assets | 19.023 | 18.863 | 18.543 | 18.203 | 17.851 | 17.512 | 17.124 | 17.177 | 17.125 | - |
| Inventories | 50 | 50 | 49 | 14 | 14 | 13 | 13 | 13 | 13 | - |
| Receivables | 9.589 | 9.524 | 9.363 | 9.225 | 9.046 | 8.875 | 8.678 | 8.705 | 8.679 | - |
| Cash | 9.384 | 9.289 | 9.132 | 8.964 | 8.790 | 8.624 | 8.433 | 8.459 | 8.433 | - |
| Shareholders Funds | 9.066 | 8.973 | 8.822 | 8.660 | 8.492 | 8.331 | 8.146 | 8.172 | 8.147 | - |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | - |
| Debts | 9.957 | 9.889 | 9.722 | 9.543 | 9.359 | 9.181 | 8.978 | 9.005 | 8.978 | - |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4799 - 4799" | |||||||||
| CAEN Financial Year |
4799
|
|||||||||
Comments - Stil Biotechnology S.r.l.